In vitro assessment of alkylglycosides as permeability enhancers.
series of alkylglycosides has been evaluated on human cell lines to determine its ability to open cellular tight junctions. Alkylglycosides were applied to cell monolayers; the resulting change in resistance was determined by transepithelial electrical resistance measurements. Change in resistance across cell monolayers is an indication of tight junction activation, whereas subsequent increase in resistance signifies monolayer recovery. Of the 13 alkylglycosides tested, 4 caused irreversible solubilization of cell membranes, 5 allowed a partial recovery of the monolayer after a relatively rapid reduction in resistance, and 4 induced a decrease in resistance with more complete cell recovery. Alkylglycosides allowing extensive cell recovery after removal may indicate tight junctions' activity dominance over membrane fluidity. Repeated application of alkylglycosides for 6 hours lowered resistance across cells, which returned to near-normal values after a recovery period of 48 hours. A model dye was transported across the cell monolayer only in the presence of an alkylglycoside, although recovery of cells was incomplete. Activity of the alkylglycosides was unrelated to either the carbon chain length or to the carbohydrate moiety. A direct correlation was established between the concentration of applied alkylglycoside and reduction in resistance over a constant time period. Dodecylmaltoside and octylglucoside were found to be optimal in decreasing resistance at low concentrations and allowing significant recovery of cells. Therefore these 2 alkylglycosides may be useful in facilitating drug transport across biological membranes.
Eley
J G
JG
Department of Pharmaceutical Sciences, Harrison School of Pharmacy, 302 Walker Building, Auburn University, Auburn, AL 36849, USA. eleyjohn@auburn.edu
Triumalashetty
P
P
D001692:Biological Transport; D002460:Cell Line; D002463:Cell Membrane Permeability / Q000187:drug effects*; D006027:Glycosides / Q000494:pharmacology*; D006801:Humans; D006839:Hydrocarbons, Acyclic / Q000494:pharmacology; D019108:Tight Junctions / Q000187:drug effects
D006027:Glycosides; D006839:Hydrocarbons, Acyclic